Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial growth and proliferation proteins encompass a broad and heterogeneous group of essential enzymes and structural components required for the survival, replication, and division of bacterial cells. This category includes critical targets such as penicillin-binding proteins (PBPs) involved in peptidoglycan synthesis, DNA gyrase and topoisomerase IV responsible for DNA supercoiling, and the 30S and 50S ribosomal subunits essential for protein translation. Because these proteins are fundamental to the bacterial life cycle and often differ significantly from their eukaryotic counterparts, they serve as the primary targets for the majority of antibiotic classes. Inhibition of these proteins typically results in bacteriostatic or bactericidal effects, effectively halting the progression of bacterial infections. However, the term is considered a functional category rather than a specific molecular target, as it aggregates hundreds of distinct proteins with diverse biochemical roles.
Inhibition of cell wall synthesis, inhibition of protein synthesis, inhibition of nucleic acid replication, and disruption of metabolic pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial growth and proliferation proteins.